Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults

CONCLUSION: VHD reporting appears rare with MPH compared to other adverse events and is increased in adults only. Our findings support a potential safety signal of VHD in adults exposed to MPH. A risk in that population cannot be excluded and requires further assessment.

via https://pubmed.ncbi.nlm.nih.gov/38837561/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=None&utm_content=1HYeX0emtvYgH07Wkz0a8n9otrdMd-JIklc_uo0I5vh1u9WMEy&fc=None&ff=20240606010805&v=2.18.0.post9+e462414